Lizzie Fletcher actually said...

"the rule puts individuals at great risk of having their Parkinson's or other diagnoses exposed if they participate in clinical studies."

"So with these principal concerns about participation, about PII, CBI, about getting the best possible science..."

"We want to encourage these kinds of studies, and that concern is something that I think Americans share."

"I think this is a critical place where Congress really needs to reassess whether this is a program that should continue."